Overview
Allegro is a family of patients and scientists dedicated to designing disruptive technologies. The company's mission is to develop first-in-class technology with blockbuster potential addressing unmet clinical needs in orthopedics, with pipeline candidates designed to challenge the status quo.
Key people
In the news
- We talked about the Advanced Therapies in Orthopaedics Foundation (ATiO) conference in Berlin before, where Chief Executive Officer Lucas Decuypere pitched Allegro’s innovative device for osteoarthritis to an eager audience. https://lnkd.in/eXtU3GX6 Here are some more pictures – this is what a medical conference during a heatwave looks like!
- How do you tackle ageing joints? That is the topic Chief Executive Officer Lucas Decuypere addressed in a panel on using innovation to increase lifespan at LSI Asia. Allegro is redefining osteoarthritis by looking at it from a biomechanical perspective. Hydrocelin, our lead candidate device, is a hydrogel filled with cross-linked microparticles, which function as tiny shock absorbers. It is a minimally invasive treatment, designed to increase the biomechanical function of the synovial fluid. This is precisely the kind of
- There really was no better place for Allegro to be this week than the Alliance for Advanced Therapies in Orthopaedics (AtiO) conference in Berlin. The event is dedicated to transforming the current landscape of medical therapies in orthopaedics. And that is precisely our focus – just like the many other companies with groundbreaking ideas with whom we met. Chief Executive Officer Lucas Decuypere pitched Allegro’s innovative treatment for osteoarthritis to an eager audience. With our deep understanding of engineering, we have
- CEO Lucas Decuypere is very much looking forward to pitching Allegro at the #ATiOEmergingCompanyPitchContest2026 Alliance for Advanced Therapies in Orthopaedics (AtiO) conference in Berlin this week. Allegro was handpicked among “a selection of companies pioneering early-stage products, groundbreaking ideas, poised to transform the current landscape of medical therapies in orthopaedics” – as the organisers put it. Thanks - we couldn’t agree more! Allegro’s Hydrocelin innovative device for osteoarthritis is based on our
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.